Organic Letters
Letter
(4) (a) Karmakar, R.; Pahari, P.; Mal, D. Chem. Rev. 2014, 114, 6213.
(b) Di Mola, A.; Palombi, L.; Massa, A. Curr. Org. Chem. 2012, 16, 2302.
(c) Beck, J. J.; Chou, S.-C. J. Nat. Prod. 2007, 70, 891. (d) Xioang, M. J.;
Li, Z. H. Curr. Org. Chem. 2007, 11, 833. (e) Lin, G.; Chan, S. S.-K.;
Chung, H.-S.; Li, S.-L. Chemistry and Biological Action of Natural
Occurring Phthalides. In Studies in Natural Products Chemistry; Atta-ur-
Rahman, Ed.; Elsevier: Amsterdam, 2005; Vol. 32, 611.
(5) For reactions of phthaloyl peroxides see: (a) Greene, F. D. J. Am.
Chem. Soc. 1956, 78, 2246. (b) Greene, F. D. J. Am. Chem. Soc. 1956, 78,
2250. (c) Greene, F. D.; Rees, W. W. J. Am. Chem. Soc. 1958, 80, 3432.
(d) Greene, F. D. J. Am. Chem. Soc. 1959, 81, 1503. (e) Greene, F. D.;
Adam, W.; Cantrill, J. E. J. Am. Chem. Soc. 1961, 83, 3461. (f) Jones, M.,
Jr.; DeCamp, M. R. J. Org. Chem. 1971, 36, 1536. (g) Yuan, C.; Axelrod,
A.; Varela, M.; Danysh, L.; Siegel, D. Tetrahedron Lett. 2011, 52, 2540.
(h) Yuan, C.; Liang, Y.; Hernandez, T.; Berriochoa, A.; Houk, K. N.;
Siegel, D. Nature 2013, 499, 192. (i) Eliasen, M.; Thedford, R. P.;
Claussen, K. R.; Yuan, C.; Siegel, D. Org. Lett. 2014, 16, 3628.
(j) Camelio, A. M.; Liang, Y.; Eliasen, A. M.; Johnson, T. C.; Yuan, C.;
Schuppe, A. W.; Houk, K. N.; Siegel, D. J. Org. Chem. 2015, 80, 8084.
(k) Eliasen, A. M.; Christy, M.; Claussen, K. R.; Besandre, R.; Thedford,
R. P.; Siegel, D. Org. Lett. 2015, 17, 4420.
(6) For reactions of malonoyl peroxides see: (a) Griffith, J. C.; Jones, K.
M.; Picon, S.; Rawling, M. J.; Kariuki, B. M.; Campbell, M.; Tomkinson,
N. C. O. J. Am. Chem. Soc. 2010, 132, 14409. (b) Picon, S.; Rawling, M.;
Campbell, M.; Tomkinson, N. C. O. Org. Lett. 2012, 14, 6250. (c) Jones,
K. M.; Tomkinson, N. C. O. J. Org. Chem. 2012, 77, 921. (d) Rawling, M.
J.; Rowley, J. H.; Campbell, M.; Kennedy, A. R.; Parkinson, J. A.;
Tomkinson, N. C. O. Chem. Sci. 2014, 5, 1777. (e) Dragan, A.; Kubczyk,
T. M.; Rowley, J. H.; Sproules, S.; Tomkinson, N. C. O. Org. Lett. 2015,
17, 2618. (f) Alamillo-Ferrer, C.; Davidson, S. C.; Rawling, M. J.;
Theodoulou, N. H.; Campbell, M.; Humphreys, P. G.; Kennedy, A. R.;
Tomkinson, N. C. O. Org. Lett. 2015, 17, 5132. (g) Terent’ev, A. O.; Vil,
V. A.; Mulina, O. M.; Pivnitsky, K. K.; Nikishin, G. I. Mendeleev Commun.
2014, 24, 345. (h) Terent’ev, A. O.; Vil, V. A.; Nikishin, G. I.; Adam, W.
Synlett 2015, 26, 802. (i) Terent’ev, A. O.; Vil, V. A.; Gorlov, E. S.;
Nikishin, G. I.; Pivnitsky, K. K.; Adam, W. J. Org. Chem. 2016, 81, 810.
(7) Russell, K. E. J. Am. Chem. Soc. 1955, 77, 4814.
epoxidation of 25 with m-CPBA (1.8 equiv) gave 28 stereo-
selectively (81%),17 the relative stereochemistry of which was
confirmed by single-crystal X-ray crystallographic analysis of 29
series of transformations shows that each of the distinct
functionalities within the core alkylidene phthalide product can
be manipulated selectively, allowing for effective diversification
of the products.
In summary, the reagent 4 can be prepared in a single step by
reaction of phthaloyl chloride with N-Boc-hydroxylamine 11
under basic reaction conditions. Treatment of enolates derived
from cyclic or acyclic ketones as well as esters with 2 equiv of 4
leads to an alkylidene phthalide product stereoselectivity. The
selectivity observed in the transformation can be altered by
changing the polarity of the reaction medium. Isomerization of
the products also proved possible under acidic conditions
providing a convenient method by which to prepare this
important class of heterocycle. The ability to manipulate the
functional groups in the product suggests that this trans-
formation will be applicable to the preparation of 3-substituted
phthalides which are prevalent in many naturally occurring and
biologically significant molecules.
ASSOCIATED CONTENT
* Supporting Information
■
S
The Supporting Information is available free of charge on the
Analytical data, experimental procedures, and NMR
spectra for all compounds reported (PDF)
AUTHOR INFORMATION
Corresponding Author
■
Notes
(8) Compound 4 has been synthesized previously and investigated as a
pro-inhibitor of serine β-lactamases. (a) Zinner, G.; Ruthe, V.; Hitze, M.;
Vollrath, R. Synthesis 1971, 148. (b) Tilvawala, R.; Pratt, R. F.
Biochemistry 2013, 52, 7060.
The authors declare no competing financial interest.
(9) Kato, H.; Tezuka, H.; Yamaguchi, K.; Nowada, K.; Nakamura, Y. J.
Chem. Soc., Perkin Trans. 1 1978, 1, 1029.
ACKNOWLEDGMENTS
■
We thank the University of Strathclyde for financial support and
the EPSRC Mass Spectrometry Service, Swansea, for high-
resolution spectra.
(10) Abell, A. D.; Clark, B. M.; Robinson, W. T. Aust. J. Chem. 1988, 41,
1243.
(11) Coelho, F.; Veronese, D.; Pavam, C. H.; de Paula, V. I.; Buffon, R.
Tetrahedron 2006, 62, 4563.
(12) Mor, S.; Dhawan, S. N.; Kapoor, M.; Kumar, D. Tetrahedron 2007,
63, 594.
(13) For alternative methods for the preparation of this class of
heterocycle, see ref 4.
(14) Allan, J. F.; Henderson, K. W.; Kennedy, A. R. Chem. Commun.
1999, 1325.
(15) Mukhopadhyay, R.; Kundu, N. G. Tetrahedron 2001, 57, 9475.
(16) Luche, J. L. J. Am. Chem. Soc. 1978, 100, 2226.
(17) Davies, S. G.; Fletcher, A. M.; Thomson, J. E. Org. Biomol. Chem.
2014, 12, 4544.
REFERENCES
■
(1) (a) Harvey, A. L.; Edrada-Ebel, R.; Quinn, R. J. Nat. Rev. Drug
Discovery 2015, 14, 111. (b) Cragg, G. M.; Newman, D. J. Biochim.
Biophys. Acta, Gen. Subj. 2013, 1830, 3670. (c) Newman, D. J.; Cragg, G.
M. J. Nat. Prod. 2012, 75, 311. (d) Dias, D. A.; Urban, S.; Roessner, U.
Metabolites 2012, 2, 303. (e) Mishra, B. B.; Tiwari, V. K. Eur. J. Med.
Chem. 2011, 46, 4769. (f) Carter, G. T. Nat. Prod. Rep. 2011, 28, 1783.
(h) Rishton, G. M. Am. J. Cardiol. 2008, 101, S43. (i) Harvey, A. L. Drug
Discovery Today 2008, 13, 894.
(2) (a) Kim, J.; Kim, H.; Park, S. B. J. Am. Chem. Soc. 2014, 136, 14629.
(b) Lachance, H.; Wetzel, S.; Kumar, K.; Waldmann, H. J. Med. Chem.
2012, 55, 5989. (c) Cordier, C.; Morton, D.; Murrison, S.; Nelson, A.;
O’Leary-Steele, C. Nat. Prod. Rep. 2008, 25, 719. (d) Newman, D. J. J.
Med. Chem. 2008, 51, 2589. (e) Klekota, J.; Roth, F. P. Bioinformatics
2008, 24, 2518. (f) Evans, B. E.; Rittle, K. E.; Bock, M. G.; DiPardo, R.
M.; Freidinger, R. M.; Whitter, W. L.; Lundell, G. F.; Veber, D. F.;
Anderson, P. S.; Chang, R. S. L.; Lotti, V. J.; Cerino, D. J.; Chen, T. B.;
Kling, P. J.; Kunkel, K. A.; Springer, J. P.; Hirshfield, J. J. Med. Chem.
1988, 31, 2235.
(3) (a) O’Connor, C. J.; Beckmann, H. S. G.; Spring, D. R. Chem. Soc.
Rev. 2012, 41, 4444. (b) Wetzel, S.; Bon, R. S.; Kumar, K.; Waldmann,
H. Angew. Chem., Int. Ed. 2011, 50, 10800.
D
Org. Lett. XXXX, XXX, XXX−XXX